Cancer Symposia

The International Society for Preventive Onco|ogy (ISPO), the World Health Organization (WHO), and the French National League Against Cancer (LNFCC) are sponsoring three meedngs to discuss cancer. The cosponsors of the April 9 to 15, 1989, meetings are the University of Massachusetts Medical School, the University of Nice Faculty of Medicine, the French National Federation of Can- cer Centers, and the Merieux Foundation. The meetings will be held at the Beach Regency Hotel, Nice, France.

IMMUNOLOGY A N D BIOLOGIC CONTROL OF CANCER

Thi rd International Symposium on immunobiology in Clinical Oncology

Objectives. This meeting will focus on an appraisal of recent experimental and clinical data on (I) neoplastic relevance of virology and immune dysfunctions and (2) multifactorial etiology of immune deficiencies and cancers, for prevention and improved management of immune suppressed patients with solid and hema- tologic neoplasias.

Program. The program includes these topics: congenital and chemically induced immune deficiency; aging; viral oncogenesis; role of retroviruses in immune dys- functions; lymphoproliferative diseases; clinical experience with monoclonal anti- bodies for immunodiagnosis and cancer treatment; bone marrow transplantation; treatment of graft versus host disease; and other immunotherapeutic approaches.

The symposium meets April 9 to 11, 1989.

CANCER IN PATIENTS W1TH AIDS

First internat ional Symposium on AIDS-Associated Neoplasms Objectives. This meeting will focus on an appraisal of recent experimental and clinical data on pathogenesis of cancer in virally induced immune deficiency, and new approaches to cancer therapy of immune suppressed patients.

Program. The program includes these topics: epidemiology; developmental co- factors; precursor disorders; Kaposi's sarcoma; lymphomas and other neoplasms; diagnosis; therapeutic approaches; and vaccination problems and prospects.

The symposium meets April 12, 1989.

PERSPECTIVES A N D TRENDS IN CANCER PREVENTION A N D DETECTION

Seventh lncernation~l Symposium on Prevention and Detect/on o f Cancer

Objectives. The focus of this meeting is to form a consensus on crucial issues concerning cancer causes, risks, clinical management and public health measures, and optimal implementation of priorities and strategies to ma.x/mize available resources for improved cancer control.

Human Immunology 22, 283-284 (1988) 2 8 3 © American Society for Histocomparibility and Immunogenerics, 1988 0198-8859/88/$3.50

284 Symposia

Program. The program includes these topics: current knowledge of multifactoriai cancer etiology and cofactor influences including genetics, environmental and occupational effects, viruses, and life-style; clinical and laboratory assessment of the risk for cancer and the role of biomarkers; and effective prevention measures and detection methods.

DETAILS

Plenary, workshop, poster sessions, and roundtables are presented in Engfish. The programs are targeted to virologists, immunologists, pathologists, public health officials, nurses, epidemiologists, toxicologists, pharmacologists, and ex- perimental and clinical oncologists.

INQUIRIES

Address inquiries to Symposium Office, International Society for Preventivt Oncology-ISPO, 217 East 85th Street, Suite 303, New York, New York 10028 Tel: 212-534-4991. Telex: 8100070344 SODAUD or M. Schneider, MD, Cert. tre Antoine Lacassagne, 36 Vole Romaine, 06054 Nice Cedex, France. Tel 93817133, ext 2514. Telex: 470 344F.